Screening for colorectal cancer, where are we now?

Sarah Kraus*, Nadir Arber

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


The most important disadvantage of the currently available colonoscopes is the need for bowel preparation [23]. Preparation less virtual would be an attractive option. The cost of the new endoscopic methods for colorectal cancer screening is another issue, and needs to be reduced to less than US$200 if large-scale use is intended. Proof of concept for the new endoscopes has been achieved, although significant improvements are still required before colonoscopy can be replaced.

Original languageEnglish
Pages (from-to)422-424
Number of pages3
JournalEuropean Journal of Cancer
Issue numberSUPPL. 1
StatePublished - Sep 2009


Dive into the research topics of 'Screening for colorectal cancer, where are we now?'. Together they form a unique fingerprint.

Cite this